Retrieve available abstracts of 8 articles: HTML format
Single Articles
September 2025
HATTER L, Holliday M, Oldfield K, Kearns C, et al Budesonide-formoterol versus salbutamol as reliever therapy in children with mild
asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised
controlled trial.
Lancet. 2025 Sep 28:S0140-6736(25)00861-X. doi: 10.1016/S0140-6736(25)00861. PubMedAbstract available
February 2025
GUTTMAN-YASSKY E, Renert-Yuval Y, Brunner PM Atopic dermatitis.
Lancet. 2025;405:583-596. PubMedAbstract available
December 2024
WEIDINGER S, Novak N Hand eczema.
Lancet. 2024;404:2476-2486. PubMedAbstract available
November 2024
SOMA T, Oie Y, Takayanagi H, Matsubara S, et al Induced pluripotent stem-cell-derived corneal epithelium for transplant surgery:
a single-arm, open-label, first-in-human interventional study in Japan.
Lancet. 2024 Nov 7:S0140-6736(24)01764-1. doi: 10.1016/S0140-6736(24)01764. PubMedAbstract available
July 2024
ZUBERBIER T, Ensina LF, Gimenez-Arnau A, Grattan C, et al Chronic urticaria: unmet needs, emerging drugs, and new perspectives on
personalised treatment.
Lancet. 2024;404:393-404. PubMedAbstract available
BRUNNER PM A novel treatment approach for atopic dermatitis.
Lancet. 2024 Jul 25:S0140-6736(24)01488-0. doi: 10.1016/S0140-6736(24)01488. PubMed
SILVERBERG JI, Wollenberg A, Reich A, Thaci D, et al Nemolizumab with concomitant topical therapy in adolescents and adults with
moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two
replicate, double-blind, randomised controlled phase 3 trials.
Lancet. 2024 Jul 24:S0140-6736(24)01203-0. doi: 10.1016/S0140-6736(24)01203. PubMedAbstract available
February 2024
ROSAS-SALAZAR C, Gebretsadik T, Dupont WD, Hartert TV, et al The INSPIRE study: RSV infection during infancy - Authors' reply.
Lancet. 2024;403:729-730. PubMed